I agree that this site is using cookies. You can find further informations here.
X
Suzuki, Kenshi
507  results:
?
1

Elranatamab in Japanese patients with relapsed/refractory m..:

Iida, Shinsuke ; Ito, Satoshi ; Yokoyama, Hisayuki...
Japanese Journal of Clinical Oncology.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Daratumumab for patients with myeloma with early or late re..:

Spencer, Andrew ; Moreau, Philippe ; Mateos, Maria-Victoria...
Blood Advances.  8 (2024)  2 - p. 388-398 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Combined effects of radiation and simulated microgravity on..:

Suzuki, Kenshi ; Tsuruoka, Chizuru ; Morioka, Takamitsu...
Life Sciences in Space Research.  41 (2024)  - p. 202-209 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Pembrolizumab plus single-fraction radiotherapy for patient..:

Suzuki, Kenshi
The Lancet Haematology.  11 (2024)  7 - p. e473-e475 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Isatuximab in combination with carfilzomib and dexamethason..:

Facon, Thierry ; Moreau, Philippe ; Špicka, Ivan...
Hematological Oncology.  42 (2024)  2 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
6

Prognostic impact of 1q abnormality on outcomes in patients..:

Kikuchi, Taku ; Tsukada, Nobuhiro ; Kunisada, Kodai...
Annals of Hematology.  , 2024
Link: https://doi.org/10.1007/..
 
?
7

Chromosome-scale genome assembly of an acidophilic microalg..:

Maeda, Yoshiaki ; Hirakawa, Toshiki ; Suzuki, Shigekatsu...
Microbiology Resource Announcements.  13 (2024)  2 - p. , 2024
Link: https://doi.org/10.1128/..
 
?
8

Cytomegalovirus infection during daratumumab therapy in pat..:

Kikuchi, Taku ; Tsukada, Nobuhiro ; Kunisada, Kodai...
International Journal of Hematology.  120 (2024)  1 - p. 91-95 , 2024
Link: https://doi.org/10.1007/..
 
?
9

Isatuximab with pomalidomide-dexamethasone in relapsed/refr..:

Tagami, Nami ; Uchiyama, Michihiro ; Suzuki, Kenshi...
International Journal of Hematology.  , 2024
Link: https://doi.org/10.1007/..
 
?
10

Stable States of a Microbial Community Are Formed by Dynami..:

Honjo, Masahiro ; Suzuki, Kenshi ; Katai, Junya...
Microbes and Environments.  39 (2024)  1 - p. n/a , 2024
Link: https://doi.org/10.1264/..
 
?
11

Prognostic value of the second revision of the internationa..:

Kikuchi, Taku ; Tsukada, Nobuhiro ; Kunisada, Kodai...
Hematological Oncology.  42 (2024)  1 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
12

Daratumumab plus bortezomib, cyclophosphamide, and dexameth..:

Suzuki, Kenshi ; Wechalekar, Ashutosh D. ; Kim, Kihyun...
Annals of Hematology.  102 (2023)  4 - p. 863-876 , 2023
Link: https://doi.org/10.1007/..
 
?
13

POSTER: MM-388 Idecabtagene Vicleucel (ide-cel) Versus Stan..:

Patel, Krina ; Rodríguez-Otero, Paula ; Manier, Salomon...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S220 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Late versus early response and depth of response are associ..:

Richardson, Paul G. ; Facon, Thierry ; Venner, Christopher P....
eJHaem.  4 (2023)  4 - p. 995-1005 , 2023
Link: https://doi.org/10.1002/..
 
?
15

S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS..:

Patel, Krina ; Rodríguez-Otero, Paula ; Manier, Salomon...
HemaSphere.  7 (2023)  S3 - p. e369897b , 2023
Link: https://doi.org/10.1097/..
 
1-15